Randomized Multicenter Phase Ii Trial Evaluating The Sequencing Of Pd-1 Inhibition With Pembrolizumab (P) And Standard Platinum-Based Chemotherapy (C) In Patients (Pts) With Metastatic Non-Small Cell Lung Cancer (Nsclc) (Aft-09).
JOURNAL OF CLINICAL ONCOLOGY（2019）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要